title: Update on the new Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for mineral and bone disorders (MBD)--a focus on medications.
authors.affiliation: Winnipeg Regional Health Authority, Manitoba Renal Program. craymond@exchange.hsc.mb.ca
authors.forename: Colette B
authors.initials: CB
authors.lastname: Raymond
authors.forename: Lori D
authors.initials: LD
authors.lastname: Wazny
authors.forename: Amy R
authors.initials: AR
authors.lastname: Sood
mesh_terms: D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D016903:Drug Monitoring; D014943:Global Health; D006801:Humans; D054559:Hyperphosphatemia / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D006996:Hypocalcemia / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D012720:Severity of Illness Index